IZQVF
Indivior PLC
IZQVF
(0.0)20,97 USD
-10.35% ROA
0% ROE
-9.71x PER
1.272.426.490,00 USD
-204.96% DER
0% Yield
0% NPM
Indivior PLC Stock Analysis
Indivior PLC Fundamental Analysis
Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.
| # | Analysis | Rating |
|---|---|---|
| 1 |
ROE
Unidentified ROE |
|
| 2 |
ROA
Unidentified ROA |
|
| 3 |
PBV
Unidentified ROA |
|
| 4 |
DER
Unidentified DER |
|
| 5 |
Revenue Growth
Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option. |
|
| 6 |
Net Profit Growth
Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors. |
|
| 7 |
Assets Growth
Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option. |
|
| 8 |
Graham Number
Unidentified Graham Number |
|
| 9 |
Dividend Growth
The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity. |
|
| 10 |
Dividend
Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges. |
|
| 11 |
Buffet Intrinsic Value
The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value. |
Indivior PLC Technical Analysis
Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.
| # | Analysis | Recommendation |
|---|---|---|
| 1 | Awesome Oscillator | Sell |
| 2 | MACD | Buy |
| 3 | RSI | Hold |
| 4 | Stoch RSI | Hold |
Indivior PLC Price Chart
Financial Statements
Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.
Income Statements
An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.
Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.
| Year | Revenue | Growth |
|---|---|---|
| 2016 | 968.885.463 | |
| 2017 | 1.148.105.410 | 15.61% |
| 2018 | 959.924.667 | -19.6% |
| 2019 | 815.158.372 | -17.76% |
| 2020 | 689.681.478 | -18.19% |
| 2021 | 777.481.856 | 11.29% |
| 2022 | 884.629.755 | 12.11% |
| 2023 | 1.119.333.042 | 20.97% |
| 2024 | 1.198.430.852 | 6.6% |
Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.
| Year | Research and Development Expenses | Growth |
|---|---|---|
| 2016 | 108.976.720 | |
| 2017 | 93.487.082 | -16.57% |
| 2018 | 63.994.977 | -46.09% |
| 2019 | 55.036.170 | -16.28% |
| 2020 | 42.638.731 | -29.08% |
| 2021 | 51.111.323 | 16.58% |
| 2022 | 70.691.833 | 27.7% |
| 2023 | 108.553.799 | 34.88% |
| 2024 | 108.219.508 | -0.31% |
General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.
| Year | General and Administrative Expenses | Growth |
|---|---|---|
| 2016 | 0 | |
| 2017 | 0 | 0% |
| 2018 | 0 | 0% |
| 2019 | 0 | 0% |
| 2020 | 447.000.000 | 100% |
| 2021 | 239.000.000 | -87.03% |
| 2022 | 545.000.000 | 56.15% |
| 2023 | 575.000.000 | 5.22% |
| 2024 | 980.000.000 | 41.33% |
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.
| Year | EBITDA | Growth |
|---|---|---|
| 2016 | 350.740.203 | |
| 2017 | 436.973.330 | 19.73% |
| 2018 | 332.391.820 | -31.46% |
| 2019 | 238.836.206 | -39.17% |
| 2020 | 121.520.375 | -96.54% |
| 2021 | 205.428.193 | 40.85% |
| 2022 | 225.821.139 | 9.03% |
| 2023 | 292.890.439 | 22.9% |
| 2024 | 240.487.812 | -21.79% |
Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.
| Year | Gross Profit | Growth |
|---|---|---|
| 2016 | 858.077.202 | |
| 2017 | 1.025.206.661 | 16.3% |
| 2018 | 825.248.669 | -24.23% |
| 2019 | 650.049.861 | -26.95% |
| 2020 | 573.490.936 | -13.35% |
| 2021 | 639.874.448 | 10.37% |
| 2022 | 715.754.819 | 10.6% |
| 2023 | 913.490.461 | 21.65% |
| 2024 | 733.487.780 | -24.54% |
Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.
| Year | Net Profit | Growth |
|---|---|---|
| 2016 | 32.051.976 | |
| 2017 | 60.924.166 | 47.39% |
| 2018 | 262.665.953 | 76.81% |
| 2019 | 139.148.053 | -88.77% |
| 2020 | -157.763.305 | 188.2% |
| 2021 | 205.000.000 | 176.96% |
| 2022 | -52.037.044 | 493.95% |
| 2023 | 2.000.000 | 2701.85% |
| 2024 | -428.869.900 | 100.47% |
EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.
| Year | Earning per Share (EPS) | Growth |
|---|---|---|
| 2016 | 0 | |
| 2017 | 0 | 0% |
| 2018 | 2 | 100% |
| 2019 | 1 | 0% |
| 2020 | -1 | 100% |
| 2021 | 1 | 200% |
| 2022 | 0 | 0% |
| 2023 | 0 | 0% |
| 2024 | -3 | 100% |
Cashflow Statements
Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.
Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.
| Year | Free Cashflow | Growth |
|---|---|---|
| 2016 | 340.666.723 | |
| 2017 | 264.704.998 | -28.7% |
| 2018 | 250.249.018 | -5.78% |
| 2019 | 149.532.236 | -67.35% |
| 2020 | -209.995.751 | 171.21% |
| 2021 | 313.548.308 | 166.97% |
| 2022 | -9.818.310 | 3293.51% |
| 2023 | -376.866.019 | 97.39% |
| 2024 | 83.825.860 | 549.58% |
Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.
| Year | Operating Cashflow | Growth |
|---|---|---|
| 2016 | 372.718.699 | |
| 2017 | 309.872.914 | -20.28% |
| 2018 | 289.410.123 | -7.07% |
| 2019 | 156.801.164 | -84.57% |
| 2020 | -205.731.878 | 176.22% |
| 2021 | 346.967.250 | 159.29% |
| 2022 | -3.927.324 | 8934.7% |
| 2023 | -322.589.120 | 98.78% |
| 2024 | 87.829.313 | 467.29% |
Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.
| Year | Capital Expenditure | Growth |
|---|---|---|
| 2016 | 32.051.976 | |
| 2017 | 45.167.916 | 29.04% |
| 2018 | 39.161.105 | -15.34% |
| 2019 | 7.268.928 | -438.75% |
| 2020 | 4.263.873 | -70.48% |
| 2021 | 33.418.942 | 87.24% |
| 2022 | 5.890.986 | -467.29% |
| 2023 | 54.276.899 | 89.15% |
| 2024 | 4.003.453 | -1255.75% |
Balance Sheet
Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.
Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.
| Year | Equity | Growth |
|---|---|---|
| 2016 | -294.999.874 | |
| 2017 | -202.999.970 | -45.32% |
| 2018 | 65.999.989 | 407.58% |
| 2019 | 209.000.112 | 68.42% |
| 2020 | 81.999.961 | -154.88% |
| 2021 | 202.602.827 | 59.53% |
| 2022 | 51.275.584 | -295.13% |
| 2023 | 67.903.984 | 24.49% |
| 2024 | -121.019.144 | 156.11% |
Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.
| Year | Assets | Growth |
|---|---|---|
| 2016 | 1.208.999.487 | |
| 2017 | 1.443.999.788 | 16.27% |
| 2018 | 1.546.999.762 | 6.66% |
| 2019 | 1.652.000.891 | 6.36% |
| 2020 | 1.530.999.274 | -7.9% |
| 2021 | 1.828.415.666 | 16.27% |
| 2022 | 1.778.558.982 | -2.8% |
| 2023 | 1.951.240.978 | 8.85% |
| 2024 | 1.535.242.860 | -27.1% |
Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.
| Year | Liabilities | Growth |
|---|---|---|
| 2016 | 1.503.999.362 | |
| 2017 | 1.646.999.759 | 8.68% |
| 2018 | 1.480.999.772 | -11.21% |
| 2019 | 1.443.000.778 | -2.63% |
| 2020 | 1.448.999.312 | 0.41% |
| 2021 | 1.625.812.839 | 10.88% |
| 2022 | 1.727.283.398 | 5.87% |
| 2023 | 1.951.240.978 | 11.48% |
| 2024 | 1.656.262.004 | -17.81% |
Dividends
Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.
| Year | Dividends | Growth |
|---|---|---|
| 2015 | 0 | |
| 2016 | 0 | 0% |
Indivior PLC Profile
About Indivior PLC
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
- CEO
- Mr. Mark Crossley
- Employee
- 1.000
- Address
-
10710 Midlothian Turnpike
North Chesterfield, 23235
Indivior PLC Executives & BODs
| # | Name | Age |
|---|---|---|
| 1 |
Ms. Nina DeLorenzo Chief Global Impact Officer |
70 |
| 2 |
Mr. Jon Fogle Chief HR Officer |
70 |
| 3 |
Ms. Cynthia Cetani Chief Integrity & Compliance Officer |
70 |
| 4 |
Mr. Richard Simkin Chief Commercial Officer |
70 |
| 5 |
Mr. Jason Thompson Vice President of Investor Relations |
70 |
| 6 |
Mr. Jeffrey W. Burris Chief Legal Officer |
70 |
| 7 |
Mr. Hillel West Chief Manufacturing & Supply Officer |
70 |
| 8 |
Mr. Ryan Preblick Chief Financial Officer & Executive Director |
70 |
| 9 |
Dr. Christian Heidbreder Chief Scientific Officer |
70 |
| 10 |
Mr. Mark Crossley Chief Executive Officer & Executive Director |
70 |
Indivior PLC Competitors
